CRANFORD, N.J.--(BUSINESS WIRE)--Akrimax Pharmaceuticals, LLC, today announced the appointment of Donald C. Olsen as President effective immediately, where he will lead the company in growing sales of existing products and expanding the future product offerings to patients. Mr. Olsen has over thirty years of pharmaceutical industry experience and has served in a number of executive management roles. He most recently held the position of Executive Vice President, Business Development at Cempra Pharmaceuticals, Inc. Mr. Olsen also spent twenty nine years with the Johnson & Johnson Pharmaceuticals Group in numerous roles of increasing responsibility in sales, marketing and business development, culminating in being appointed Vice President, Licensing and Business Development. He possesses extensive industry experience and a track record of accomplishments in both domestic and international markets.
